Navigation Links
CuraGen in Medical News

CuraGen Reports First Quarter 2009 Financial Results

...ANFORD, Conn., April 23 /PRNewswire-FirstCall/ -- curagen Corporation (Nasdaq: CRGN ) , today reported its...uring the three month period ended March 31, 2009, curagen utilized $4.1 million of cash and investments for ...n of cash and investments. As of March 31, 2009, curagen had $14 million of outstanding 4% convertible subo...

Exagen Diagnostics Names John Alsobrook, Ph.D., Vice President and Chief Operating Officer

...ltant for clients including Genaissance Pharmaceuticals, Amersham Health, G.E. Healthcare and Massachusetts General Hospital. Alsobrook also worked at curagen Corp. as genetics supervisor for drug discovery and as senior research scientist for pharmacogenomics. From 1996-2000, Alsobrook was associate faculty...

CuraGen to Present at the Rodman & Renshaw Annual Global Investment Conference

... BRANFORD, Conn., Nov. 5 /PRNewswire-FirstCall/ -- curagen Corporation (Nasdaq: CRGN ), a clinical-stage bio...archived for 90 days thereafter. About CuraGen curagen Corporation (Nasdaq: CRGN ) is a dedicated clinic...ng diverse approaches for the treatment of cancer. curagen Corporation is headquartered in Branford, Connecti...

CuraGen to Present at The Seventh Annual Needham & Company Biotechnology and Medical Technology Conference

... BRANFORD, Conn., June 6 /PRNewswire-FirstCall/ -- curagen Corporation (Nasdaq: CRGN ) announced today that ...archived for 30 days thereafter. About CuraGen curagen Corporation (Nasdaq: CRGN ) is a clinical-stage b... promising approaches for the treatment of cancer. curagen Corporation is headquartered in Branford, Connecti...

CuraGen Corporation Regains NASDAQ Listing Compliance

... BRANFORD, Conn., May 29 /PRNewswire-FirstCall/ -- curagen Corporation (Nasdaq: CRGN ) today announced that ...8, NASDAQ had previously informed the Company that curagen had until July 28, 2008 to regain compliance with ...hank our shareholders who have shown confidence in curagen during this notification period," stated Dr. Timot...

CuraGen Sells 5 Million TopoTarget Shares for Approximately $12 Million

... BRANFORD, Conn., May 22 /PRNewswire-FirstCall/ -- curagen Corporation (Nasdaq: CRGN ) announced today the c...CuraGen's ownership in belinostat. After expenses, curagen will receive approximately $12 million in cash. ...n April 22, 2008, bring the total cash realized by curagen to approximately $38 million," stated Dr. Timothy ...

Pharsight Strengthens Senior Management Team

...g strategies and implementing solutions to improve R&D productivity. Before this, Dr. Murphy served as Vice President and Chief Information Officer at curagen Corporation, a publicly traded biopharmaceutical company. While at CuraGen, he directed business development and information technology services for t...

CuraGen Reports First Quarter 2008 Financial Results

...RANFORD, Conn., April 22 /PRNewswire-FirstCall/ -- curagen Corporation (Nasdaq: CRGN ) today reported its fi...ter of 2008. For the quarter ended March 31, 2008, curagen reported a net loss of $6.8 million, or $0.12 per ...e same period in 2007. During the first quarter, curagen incurred costs totaling $1.5 million for milestone...

CuraGen and TopoTarget Report Belinostat Results Presented at ASH and Provide Regulatory Update Following End-of-Phase II Meeting with FDA

...BRANFORD, Conn., Dec. 10 /PRNewswire-FirstCall/ -- curagen Corporation (Nasdaq: CRGN ), a clinical-stage bio...tology (ASH) 49th Annual Meeting in Atlanta, GA. curagen and TopoTarget also reported today that the prelim...tment of PTCL. Based on this meeting with the FDA, curagen plans to submit a clinical trial protocol to the F...

CuraGen Reports Third Quarter 2007 Financial Results

...BRANFORD, Conn., Oct. 25 /PRNewswire-FirstCall/ -- curagen Corporation (Nasdaq: CRGN ), a clinical-stage bio...of 2007. For the quarter ended September 30, 2007, curagen reported a net loss of $9.9 million, or $0.18 per ...he same period in 2006. As of September 30, 2007, curagen had cash and investments of $153.6 million. Of the...
CuraGen in Medical Technology

CuraGen Announces Expansion of CR011-vcMMAE Phase II Trial in Advanced Breast Cancer

...RANFORD, Conn., June 17 /PRNewswire-FirstCall/ -- curagen Corporation (Nasdaq: CRGN ) announced today tha...e Professor of Clinical Medicine, /Weill Cornell. curagen anticipates presenting updated results from this s...n antibody-drug conjugate (ADC) being developed by curagen that consists of a fully-human monoclonal antibody...

CuraGen Updates CR011-vcMMAE Data at ASCO

...BRANFORD, Conn., June 2 /PRNewswire-FirstCall/ -- curagen Corporation (Nasdaq: CRGN ) reported three data...n antibody-drug conjugate (ADC) being developed by curagen that consists of a fully-human monoclonal antibody...ancer who have failed other therapies. About curagen CuraGen Corporation (Nasdaq: CRGN ) is a clinica...

CuraGen to Present CR011-vcMMAE Data at ASCO

...BRANFORD, Conn., May 28 /PRNewswire-FirstCall/ -- curagen Corporation (Nasdaq: CRGN ) today announced pla...n antibody-drug conjugate (ADC) being developed by curagen that consists of a fully-human monoclonal antibody...n survival is less than nine months. About curagen ...

CuraGen Announces Preliminary Data from Ongoing Phase II Study Showing Clinical Activity of CR011-vcMMAE in Patients with Metastatic Melanoma

... BRANFORD, Conn., Nov. 3 /PRNewswire-FirstCall/ -- curagen Corporation (Nasdaq: CRGN ) announced today preli...g schedules of CR011-vcMMAE," commented Dr. Hwu. curagen is currently enrolling patients into a Phase I por...st cancer who have received previous chemotherapy. curagen anticipates providing updated data from the ongoin...

CuraGen to Host Conference Call and Webcast to Discuss Third Quarter 2008 Financial Results and CR011-vcMMAE Phase II Trial Results on November 3, 2008

...BRANFORD, Conn., Oct. 29 /PRNewswire-FirstCall/ -- curagen Corporation (Nasdaq: CRGN ), a clinical-stage bio...ays at http://www.curagen.com . About CuraGen curagen Corporation (Nasdaq: CRGN ) is a dedicated clinic...ng diverse approaches for the treatment of cancer. curagen Corporation is headquartered in Branford, Connecti...

CuraGen Completes Enrollment in Phase II Trial of CR011-vcMMAE in Metastatic Melanoma

...RANFORD, Conn., Sept. 11 /PRNewswire-FirstCall/ -- curagen Corporation (Nasdaq: CRGN ), a clinical-stage bio...011-vcMMAE for the treatment of advanced melanoma. curagen also announced today that Phase II results from th...rate, time to response and duration of response. curagen is also continuing the Phase I portion of the tria...

CuraGen Reports Second Quarter 2008 Financial Results and Clinical Progress of CR011-vcMMAE

...BRANFORD, Conn., July 29 /PRNewswire-FirstCall/ -- curagen Corporation (Nasdaq: CRGN ), a clinical-stage bio...011-vcMMAE. For the quarter ended June 30, 2008, curagen reported income from continuing operations of $39....ly negotiated transactions. As of June 30, 2008, curagen had cash, restricted cash and investments of $95.0...

CuraGen Announces Initiation of Phase II Trial of CR011-vcMMAE in Patients with Advanced Breast Cancer

...BRANFORD, Conn., June 25 /PRNewswire-FirstCall/ -- curagen Corporation (Nasdaq: CRGN ), a clinical-stage bio... Shannon, President and Chief Executive Officer of curagen Corporation. "We are confident in our ability to c...who have failed other therapies. About CuraGen curagen Corporation (Nasdaq: CRGN ) is a dedicated clinic...

CuraGen Announces Expansion of CR011-vcMMAE Phase II Trial in Melanoma

...BRANFORD, Conn., June 11 /PRNewswire-FirstCall/ -- curagen Corporation (Nasdaq: CRGN ), a clinical-stage bio... Shannon, President and Chief Executive Officer of curagen Corporation. "This trial is enrolling well, and we... cancer in the third quarter of 2008. Furthermore, curagen is conducting preclinical research to determine th...

CuraGen Announces Data From Ongoing Phase I/II Trial Showing Clinical Activity of CR011-vcMMAE in Metastatic Melanoma

... BRANFORD, Conn., June 1 /PRNewswire-FirstCall/ -- curagen Corporation (Nasdaq: CRGN ) today presented encou... Shannon, President and Chief Executive Officer of curagen Corporation. "Based on these promising results in ...need in this patient population. About CuraGen curagen Corporation (Nasdaq: CRGN ) is a clinical-stage b...
CuraGen in Biological News

Massey researchers induce cell death in leukemia

...of translational research, interactions between bortezomib and romidepsin (Gloucester Pharmaceuticals) and bortezomib with belinostat (aka PXD101 from curagen Corporation and TopoTarget A/S), were examined in human CLL cells isolated from five patients. Bortezomib dramatically potentiated the lethality of bo...
CuraGen in Biological Technology

CuraGen Reports Second Quarter 2009 Financial Results

...RANFORD, Conn., July 31 /PRNewswire-FirstCall/ -- curagen Corporation (Nasdaq: CRGN ) today reported its ...are in connection with the proposed merger between curagen Corporation and Celldex Therapeutics, Inc. The se...e three and six month periods ended June 30, 2009, curagen utilized $3.8 million and $7.8 million, respective...

CuraGen Reports Fourth Quarter 2008 Financial Results; Provides Milestone and Financial Guidance for First Half of 2009

...BRANFORD, Conn., Jan. 29 /PRNewswire-FirstCall/ -- curagen Corporation (Nasdaq: CRGN ), today reported its f...ng the three month period ended December 31, 2008, curagen utilized $3.8 million of cash and investments and ...on of cash and investments. At December 31, 2008, curagen has outstanding $19 million of 4% convertible subo...

CuraGen Reports Third Quarter 2008 Financial Results

... BRANFORD, Conn., Nov. 3 /PRNewswire-FirstCall/ -- curagen Corporation (Nasdaq: CRGN ), today reported its f...uarter with $91.4 million of cash and investments. curagen expects to utilize an average of $3 to $4 million ...mately $79 to $81 million in cash and investments. curagen is also pursuing partnership opportunities around ...

CuraGen Repurchases $50.9 Million of 2011 Convertible Debt for $43.2 Million

... BRANFORD, Conn., May 14 /PRNewswire-FirstCall/ -- curagen Corporation (Nasdaq: CRGN ) announced today the c...discount of approximately 15.1% off of face value. curagen currently has approximately $100 million or $1.72 ...ding. With the completion of these transactions, curagen will eliminate a total of approximately $5.6 milli...

CuraGen Sells Ownership of Belinostat to TopoTarget A/S

... - curagen to receive approximately $45 million in cash, stoc...RANFORD, Conn., April 22 /PRNewswire-FirstCall/ -- curagen Corporation (Nasdaq: CRGN ), a clinical-stage bio...to future net sales and sublicenses of belinostat. curagen will no longer have any funding requirements for b...

TopoTarget Successfully Buys Back Full Control of Belinostat

...duct TopoTarget Acquires US & RoW Rights From curagen Corporation COPENHAGEN, April 22 /PRNewswire/ --...tiple cancer indications jointly by TopoTarget and curagen Corporation since 2004. TopoTarget, which has alre... its flexible dosing, and its lack of toxicity." curagen has accepted to sell their rights back to TopoTarg...

CuraGen to Present at the BIO CEO & Investor Conference

...BRANFORD, Conn., Feb. 12 /PRNewswire-FirstCall/ -- curagen Corporation (Nasdaq: CRGN ) announced today that ...'s website until March 13, 2008. About CuraGen curagen Corporation (Nasdaq: CRGN ) is a dedicated clinic...g development strengths cultivated over the years, curagen expects to make a difference by advancing its prom...

CuraGen Reports Fourth Quarter and Year End 2007 Financial Results

...BRANFORD, Conn., Jan. 31 /PRNewswire-FirstCall/ -- curagen Corporation (Nasdaq: CRGN ) today reported its co...quarter and fiscal year ended December 31, 2007. curagen reported a loss from operations for the fourth qua...r of 2006. For the year ended December 31, 2007, curagen reported a loss from operations of $59.6 million, ...

CuraGen Corporation Receives Notification from NASDAQ

...BRANFORD, Conn., Jan. 29 /PRNewswire-FirstCall/ -- curagen Corporation (Nasdaq: CRGN ), a clinical-stage bio... 28, 2008, from The NASDAQ Stock Market, notifying curagen that during the preceding 30 consecutive trading d...e effect on the listing of CuraGen's common stock. curagen is considering alternatives to regain compliance w...

CuraGen Corporation Announces Appointment of Sean Cassidy as CFO

...BRANFORD, Conn., Dec. 20 /PRNewswire-FirstCall/ -- curagen Corporation (Nasdaq: CRGN ), a clinical-stage bio... Company. "We are pleased to welcome Sean to the curagen team," commented Timothy Shannon, President and Ch...ve Wurzer for his more than 10 years of service to curagen during which he made substantial contributions acr...
Other Tags
(Date:8/1/2014)... (PRWEB) August 01, 2014 Millions of ... affects the legs and in some cases the arms, ... state that about 17 million women in the U.S. ... women dealing with the pain, embarrassment and discomfort caused ... even some physicians are unaware that this is a disease,” ...
(Date:8/1/2014)... August 01, 2014 Get the report ... with PitchBook presents the 3Q 2014 Private Equity Breakdown ... equity investment, exits and fundraising activity in the second ... help plan for private equity endeavors for the remainder ... to download it now. , About Merrill DataSite , ...
(Date:7/31/2014)... The 2013 edition of the ... listings, appellate decisions, litigation and settlement trends, trials, ... with California's Proposition 65. , The Handbook is ... history and trends impacting California's Proposition 65. ... the series which adds approximately 200 pages devoted ...
(Date:7/31/2014)... Women who recently used birth control pills containing ... increased risk for breast cancer, whereas women using some ... Cancer Research , a journal of the American ... use of contemporary oral contraceptives [birth control pills] in ... cancer risk relative to never or former oral contraceptive ...
(Date:7/31/2014)... July 31, 2014 Leelanau Peninsula’s newest winery, ... 3, 2014 at 7788 East Horn Road in Lake Leelanau. ... Trail , Aurora Cellars is the 25th winery along the ... the popular wine tour events, making its trail event debut ... 2014. , Owners David and Faye Mathia opened the ...
Breaking Medicine News(10 mins):Health News:Lipedema Centers Works With Insurers To Gain Coverage For Lipedema Treatment 2Health News:Register to Download Merrill DataSite's Report: PitchBook 3Q 2014 Private Equity Breakdown Report 2Health News:Save 25% on the Proposition 65 Handbook - 2013 Edition Through August 31 2Health News:Recent use of some birth control pills may increase breast cancer risk 2Health News:Aurora Cellars Joins the Leelanau Peninsula Wine Trail 2
(Date:7/31/2014)... hazard lurks beneath many of the roughly 156,000 ... hazard is corrosion in parts of underground gas ... and contamination of groundwater, a source of drinking ... states have reported many rapidly corroding gas storage ... are generally associated with use of gasoline-ethanol blends ...
(Date:7/31/2014)... available in German . ... gases similar to a sponge that soaks up liquids. ... hydrogen or greenhouse gases. However, loading of many MOFs ... Technology (KIT) now report in Nature Communications ... MOF surface. This can be prevented by water-free synthesis ...
(Date:7/31/2014)... alters how the brain processes speech, potentially increasing ... neuroscientists at The University of Texas at Dallas. ... Ear and Hearing , researchers demonstrated for ... the brain,s recognition of speech sounds. , Noise-induced ... population, affecting an estimated 15 percent of Americans ...
Breaking Biology News(10 mins):NIST corrosion lab tests suggest need for underground gas tank retrofits 2Free pores for molecule transport 2UT Dallas study reveals effect of loud noises on brain 2
Other Contents